Form 8-K - Current report:
SEC Accession No. 0001193125-25-146994
Filing Date
2025-06-25
Accepted
2025-06-25 16:32:27
Documents
18
Period of Report
2025-06-25
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d51953d8k.htm   iXBRL 8-K 28615
2 EX-99.1 d51953dex991.htm EX-99.1 16820
7 GRAPHIC g51953dsp05a.jpg GRAPHIC 4754
8 GRAPHIC g51953dsp05b.jpg GRAPHIC 8136
9 GRAPHIC g51953dsp5a.jpg GRAPHIC 4117
10 GRAPHIC g51953dspa.jpg GRAPHIC 5413
  Complete submission text file 0001193125-25-146994.txt   234810

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA dbvt-20250625.xsd EX-101.SCH 3100
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dbvt-20250625_def.xml EX-101.DEF 13866
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE dbvt-20250625_lab.xml EX-101.LAB 22897
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dbvt-20250625_pre.xml EX-101.PRE 14704
20 EXTRACTED XBRL INSTANCE DOCUMENT d51953d8k_htm.xml XML 5888
Mailing Address 107 AVENUE DE LA REPUBLIQUE CHATILLON I0 92320
Business Address 107 AVENUE DE LA REPUBLIQUE CHATILLON I0 92320 33(0)155427878
DBV Technologies S.A. (Filer) CIK: 0001613780 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36697 | Film No.: 251074024
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)